$BTMD Cashflow Statement | Understand Stock

$BTMD

$1.18 +$0.03 (2.61%) Close

$BTMD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Activities
Net income
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Transaction costs allocated to warrant liabilities
Net gain on investments held in Trust Account
Excess of private placement warrants fair value over purchase price
Depreciation and amortization
Bad debt expense
Amortization of debt issuance costs
Write-off of capitalized software
Provision for obsolete inventory
Non-cash lease expense
Non-cash interest on share repurchase liability
Shares issued in settlement of litigation
Non-cash sponsor share transfers
Non-cash fees under SEPA
Share-based compensation expense
Loss from change in fair value of warrant liability
(Gain) loss from change in fair value of earnout liabilities
Loss from extinguishment of debt
Deferred income taxes
Changes in operating assets and liabilities:
Due From Sponsor
Prepaid expenses
Accounts receivable
Inventory
Other assets
Accounts payable
Deferred revenue
Accrued expenses
Franchise tax payable
Payments pursuant to TRA
Operating lease liabilities

Net cash provided by operating activities
Investing Activities
Cash deposited into Trust Account
Purchases of property and equipment
Purchases of capitalized software
Acquisitions, net of cash acquired
Net cash used in investing activities

Financing Activities
Proceeds from initial public offering, net of underwriter's discount paid
Proceeds from sale of Class B common stock to Sponsor
Proceeds from Sponsor note
Repayment of Sponsor note
Proceeds from sale of private placement warrants
Proceeds from the business combination
Repurchases of Class A common stock
Borrowings on revolving loans
Principal repayments on term loan
Borrowings on term loan
Extinguishment of Bank of America term loan
Debt issuance costs
Settlement of phantom equity rights
Settlement of RSUs
Payments on repurchase liability
Proceeds from exercise of stock options
Issuance of stock under purchase plan
Distributions
Capitalized transaction costs
Proceeds from issuance of shares under SEPA
SEPA transaction costs
Net cash used in financing activities

Increase in cash
Cash at beginning of period
Cash at end of period
Deferred underwriting fee payable
Initial classification of warrant liabilities
Remeasurement of Class A common stock subject to possible redemption to redemption value
Reclassification of deferred offering costs to equity upon completion of the initial public offering
Effect of exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental Disclosure of Cash Flow Information
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities
Capital expenditures and capitalized software included in accounts payable
Shares issued to acquire Simpatra
Non-cash SEPA transaction costs

Comments